Piper Sandler Lifts Price Target to $33 as Q1 Sales Jump 119.6%
Piper Sandler raised its price target to $33 from $16, reflecting confidence in a rebound as Staar Surgical reported first-quarter net sales of $93.5 million, up 119.6% year-over-year. The company turned an EPS of $0.38 versus a $0.52 loss last year, citing resolved inventory and merger-related issues boosting profitability.
1. Price Target Hike
Piper Sandler increased its price target for Staar Surgical from $16 to $33, reflecting analyst optimism on continued revenue and profitability acceleration.
2. First-Quarter Sales Surge
Staar Surgical posted first-quarter net sales of $93.5 million, a 119.6% increase year-over-year driven by robust lens demand in the United States and China.
3. Earnings Turnaround
The company reported earnings per share of $0.38 versus a loss of $0.52 in the same quarter last year, marking a substantial profit improvement.
4. Resolved Operational Challenges
Management highlighted resolution of high inventory levels and previous merger-related uncertainties, establishing a stable operating foundation for future growth.